東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Myeloid-derived suppressor cells and...

Escors, David.

Linked to FindBook

Google Book

Amazon

博客來

Myeloid-derived suppressor cells and cancer

Record Type:	Electronic resources : Monograph/item
Title/Author:	Myeloid-derived suppressor cells and cancer/ by David Escors ... [et al.].
other author:	Escors, David.
Published:	Cham :Springer International Publishing : : 2016.,
Description:	ix, 102 p. :ill., digital ;24 cm.
[NT 15003449]:	Controversies in Neoplastic Myeloplasia -- Differentiation of Murine Myeloid-derived Suppressor Cells -- Human MDSCs -- Ex Vivo MDSC Differentiation Models -- Immunoregulatory myeloid cells in the tumor microenvironment -- Signal Transducer and Activation of Transcription 3: A Master Regulator of Myeloid-derived Suppressor Cells -- Future Perspectives.
Contained By:	Springer eBooks
Subject:	Suppressor cells. -
Online resource:	http://dx.doi.org/10.1007/978-3-319-26821-7
ISBN:	9783319268217

Myeloid-derived suppressor cells and cancer
Myeloid-derived suppressor cells and cancer[electronic resource] /by David Escors ... [et al.]. - Cham :Springer International Publishing :2016. - ix, 102 p. :ill., digital ;24 cm. - SpringerBriefs in immunology,2194-2773. - SpringerBriefs in immunology..

Controversies in Neoplastic Myeloplasia -- Differentiation of Murine Myeloid-derived Suppressor Cells -- Human MDSCs -- Ex Vivo MDSC Differentiation Models -- Immunoregulatory myeloid cells in the tumor microenvironment -- Signal Transducer and Activation of Transcription 3: A Master Regulator of Myeloid-derived Suppressor Cells -- Future Perspectives.

The book starts with an introduction to and history of myeloid-derived suppressor cells (MDSCs), followed by a description of their differentiation, their role in the tumour microenvironment and their therapeutic targeting. It closes with an outlook on future developments. In cancer patients, myelopoiesis is perturbed and instead of generating immunogenic myeloid cells (such as dendritic cells, inflammatory macrophages and granulocytes), there is an increase in highly immature MDSCs. These cells are distributed systemically, resulting in general immunosuppression. They also infiltrate tumours, promoting their progression and metastasis by inhibiting the natural anti-tumour immune response. As these cells also interact with classical anti-neoplastic treatments, they have become major therapeutic targets in the pharmaceutical industry and in oncology research.

ISBN: 9783319268217

Standard No.: 10.1007/978-3-319-26821-7doiSubjects--Topical Terms:

2186367
Suppressor cells.

LC Class. No.: QR185.8.S96

Dewey Class. No.: 616.079

Myeloid-derived suppressor cells and cancer
LDR:02226nmm m2200325 m 4500 001 2032384
003 DE-He213
005 20160908163704.0
006 m d
007 cr nn 008maaau
008 161011s2016 gw s 0 eng d
020 $a 9783319268217 $q (electronic bk.)
020 $a 9783319268194 $q (paper)
024 7 $a 10.1007/978-3-319-26821-7 $2 doi
035 $a 978-3-319-26821-7
040 $a GP $c GP
041 0 $a eng
050 4 $a QR185.8.S96
072 7 $a MJCM $2 bicssc
072 7 $a MED044000 $2 bisacsh
082 0 4 $a 616.079 $2 23
090 $a QR185.8.S96 $b M996 2016
245 0 0 $a Myeloid-derived suppressor cells and cancer $h [electronic resource] / $c by David Escors ... [et al.].
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a ix, 102 p. : $b ill., digital ; $c 24 cm.
490 1 $a SpringerBriefs in immunology, $x 2194-2773
505 0 $a Controversies in Neoplastic Myeloplasia -- Differentiation of Murine Myeloid-derived Suppressor Cells -- Human MDSCs -- Ex Vivo MDSC Differentiation Models -- Immunoregulatory myeloid cells in the tumor microenvironment -- Signal Transducer and Activation of Transcription 3: A Master Regulator of Myeloid-derived Suppressor Cells -- Future Perspectives.
520 $a The book starts with an introduction to and history of myeloid-derived suppressor cells (MDSCs), followed by a description of their differentiation, their role in the tumour microenvironment and their therapeutic targeting. It closes with an outlook on future developments. In cancer patients, myelopoiesis is perturbed and instead of generating immunogenic myeloid cells (such as dendritic cells, inflammatory macrophages and granulocytes), there is an increase in highly immature MDSCs. These cells are distributed systemically, resulting in general immunosuppression. They also infiltrate tumours, promoting their progression and metastasis by inhibiting the natural anti-tumour immune response. As these cells also interact with classical anti-neoplastic treatments, they have become major therapeutic targets in the pharmaceutical industry and in oncology research.
650 0 $a Suppressor cells. $3 2186367
650 0 $a T cells. $3 683750
650 0 $a Cancer $x Immunotherapy. $3 656051
650 1 4 $a Biomedicine. $3 890831
650 2 4 $a Immunology. $3 611031
650 2 4 $a Cancer Research. $3 891172
650 2 4 $a Oncology. $3 751006
650 2 4 $a Cell Biology. $3 892383
700 1 $a Escors, David. $3 1568857
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a SpringerBriefs in immunology. $3 2133251
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-26821-7
950 $a Biomedical and Life Sciences (Springer-11642)